(1)
Milošević, I.; Beronja, B. THE USE OF TOCILIZUMAB IN SEVERE COVID-19: A COMPREHENSIVE REVIEW : Tocilizumab and Severe COVID-19. medi 2024, 57 (2). https://doi.org/10.5937/medi57-48405.